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Stress mobilizes elements from the neuroendocrine
system to modulate immune responses. Choliner-
gic stimulation via nicotinic receptor (nAchR) is
a major neuroendocrine signaling axis associated
with the stress response whose specific effects on
the immune system are unknown. Here, we show
that nAchR activation by topical agonist applica-
tion or deletion of the nAChR antagonist catesta-
tin (Chga/) reduced antimicrobial peptide (AMP)
activity in skin extracts and increased susceptibil-
ity to methicillin-resistant Staphylococcus aureus
and Group A Streptococcus infections. The adverse
effects on AMP expression and infection were
rescued by topical application of a nAChR antago-
nist. Stress-induced nAChR activation increased
infection in wild-type, but not Chga/ or cathelici-
din-deficient, mice. These data identify a mecha-
nism for the negative regulation of host-innate AMP
response to infection through cholinergic activation
and indicate nAChR-mediated cathelicidin dysregu-
lation as a potential mechanism for increased sus-
ceptibility to infection following prolonged stress or
nicotine use.
INTRODUCTION
Epithelia, such as the skin, prevent most exogenous pathogenic
microbes from invasion and colonization through both a physical
barrier, composed of epithelial cells, and by an outer chemical
shield comprised of antimicrobial molecules that includes
certain peptides, enzyme inhibitors, and reactive oxygen species
(Aberg et al., 2008; Radek and Gallo, 2007). Antimicrobial
peptides (AMPs) such as the cathelicidin (LL-37) (Dorschner
et al., 2001; Nizet et al., 2001), human b-defensin 2 (hBD2)
(Ganz et al., 1985; van Wetering et al., 1999), Psoriasin (Harder
et al., 1997), and RNase7 (Harder and Schroder, 2002) areCellproduced in epithelia, comprising an important innate barrier to
infection. Although expressed at relatively low levels under basal
conditions, AMPs are inducible by various stimuli such as path-
ogen challenge, 1,25 (OH)2 vitamin D (VD3), and/or external injury
(Heilborn et al., 2003; Schauber et al., 2006; Weber et al., 2005).
In addition to their direct and indirect antimicrobial activity,
AMPs have multiple roles in modulating both the immune and
wound healing responses (Lai and Gallo, 2009; Mookherjee
and Hancock, 2007). AMPs can dampen the response to septic
shock (Mookherjee et al., 2006), increase chemokines and
chemokine receptor expression (Scott et al., 2002), promote
adaptive immune responses (Davidson et al., 2004; Tani et al.,
2000), and stimulate epithelial proliferation (Heilborn et al., 2003;
Shaykhiev et al., 2005) and angiogenesis (Koczulla et al.,
2003) during wound repair. The multifunctional capacity of
these peptides orchestrates host immune responses by subtly
enhancing innate immunity, while taming exacerbated inflamma-
tory responses. Collectively, AMPs help to maintain the delicate
inflammatory balance to combat infection and promote healing,
without excessive inflammation. Thus, disrupting this tight bal-
ance via changes in AMP regulation can shift the balance to
restrict the ability of epithelia to combat infection or initiate detri-
mental inflammatory processes.
Currently, the mechanisms responsible for the negative regu-
lation of AMPs are incompletely understood, but recent studies
have determined that factors such as psychological stress (PS)
adversely affect production of AMPs in murine skin (Aberg
et al., 2007). Substantial evidence now supports the notion of
active crosstalk between the nervous, endocrine, and immune
systems and the regulation of inflammatory processes across
amultitude of cell types and tissues (Elenkov et al., 2000; Tracey,
2002). Stress mobilizes various elements from the neuroendo-
crine system to modulate immune responses. Acute stress
was typically thought to be immunoenhancing as part of the
‘‘fight-or-flight’’ response, while sustained stress tends to be
immunosuppressive (Aberg et al., 2007; Ashcraft and Bonneau,
2008; Dhabhar, 2009).
Three major pathways of the stress response include cate-
cholamines via adrenergic stimulation, glucocorticoids (GCs)
via activation of the hypothalamic-pituitary-adrenal axis, and
cholinergic stimulation via acetylcholine (Ach) (Brogden et al.,Host & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inc. 277
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tion was seen in frogs, where pharmacologic doses of noradren-
aline promoted the release of fully processed active AMPs from
the highly innervated granular glands at the skin surface (Benson
and Hadley, 1969; Zasloff, 1987). In mammals, recent studies
identified that both PS (i.e., insomnia) and topical GC applica-
tions reduced the expression of both cathelicidin (CAMP) and
b-defensin 3 (mBD-3) in murine skin, resulting in more severe
cutaneous bacterial lesions (Aberg et al., 2007). These studies
revealed that PS reduced AMPs in a GC-dependent fashion:
use of the GC receptor antagonist, RU-486, blocked PS-induced
suppression of AMP expression, suggesting a direct role for GCs
on this regulatory pathway. Although Ach is another major
signaling molecule involved in the stress response, the specific
effects of Ach on AMP regulation either in the skin or in extracu-
taneous tissues have not yet been elucidated.
The discovery of a nonneuronal cholinergic system in epi-
dermis emphasizes the intricate relationship between the
epidermis and nervous systems, because both of these tissues
evolve embryologically from the ectoderm. The epidermis con-
tains several molecules, multiple neurotransmitters, receptors,
and ion channels that are typically present within the nervous
system, and nonneuronal cholinergic activation regulates a
multitude of functions in various cell types to maintain nor-
mal homeostasis. For example, keratinocytes synthesize and
degrade Ach to allow for functions including cell proliferation,
apoptosis, migration, and permeability barrier homeostasis
(Denda et al., 2000; Grando et al., 1993). Binding of Ach to the
cell membrane elicits these diverse effects through receptor-
dependent mechanisms involving both muscarinic acetylcho-
line (mAChRs) and nicotinic acetylcholine receptors (nAChRs),
which are classified by the specificity of their respective ago-
nists, muscarine and nicotine (Grando et al., 2006). Furthermore,
we recently identified the presence of the nicotinic antagonist
catestatin (Cst) in the epidermis (Radek et al., 2008). This obser-
vation suggests that Cst could counteract the effects of
cholinergic activation in a manner important for epidermal
homeostasis.
Understanding the mechanisms that regulate AMPs and epi-
thelial homeostasis is critical for the prevention and treatment
of skin infections. Over 25% of all nosocomial infections that
involve the skin or adjacent tissue have methicillin-resistant
S. aureus (MRSA) as the primary agent (Lipsky et al., 2007).
Recent evidence also indicates that the incidence of postopera-
tive wound infections is higher in smokers than in nonsmokers
(Sorensen et al., 2003), whereas nicotinic activation has been
shown to impair host defense against pneumococcal pneumonia
(Giebelen et al., 2009). Cholinergic activation was shown to
inhibit local proinflammatory production of cytokines and modu-
late lymphocyte activation, since the vagus nerve innervates
major organs involved in the response to endotoxin (De Rosa
et al., 2009; Pavlov et al., 2006). This response was later termed
the ‘‘cholinergic anti-inflammatory pathway’’ and indicates the
promiscuous nature of nAChR activation on immune function
(Bernik et al., 2002). Although the immunosuppressive effect of
nicotinic stimulation has been extensively studied in immune
cells and other epithelia, the influence of nAChR stimulation on
keratinocyte innate immune function, specifically AMP activity,
has not yet been examined. Hence, we hypothesized that the278 Cell Host & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inimmunosuppression and susceptibility to infection induced by
nAChR signaling could be linked to altered AMP activity, and
that Cst could function within this pathway to regulate these
effects. In this study, we explored the interrelationship between
nAChR signaling and AMP activity in epidermis and report
here that control of nicotinic activation dramatically alters
susceptibility to infection through alterations of epidermal AMP
production.RESULTS
Nicotinic Stimulation Decreases Antimicrobial
Activity from Skin
Nicotine increases the incidence of skin and lung infections, but
the mechanism responsible for this increase in susceptibility is
unknown (Giebelen et al., 2009; Sorensen et al., 2003). Because
microbial survival is inhibited by AMPs, we questioned whether
the increased susceptibility to infection could be due to a
decrease in AMP production. First, to directly evaluate the
effects of nicotine on epithelial AMP production, mice were
treated topically with nicotine and their skin was subsequently
isolated for analysis of extractable AMPs by radial diffusion
assay (Lehrer et al., 1991). Peptide extracts were partially puri-
fied by high-pressure liquid chromatography (HPLC) prior to
analysis of antimicrobial action in order to link activity within
different fractions with specific AMP populations. Extract frac-
tions from nicotine-treated mice exhibited much smaller zones
of inhibition compared with vehicle-treated extracts when as-
sayed against the AMP-sensitive Staphylococcus aureusmutant
DmprF, consistent with reduced antimicrobial activity in epi-
dermis of nicotine-treated mice (Figure 1A). When fractions
were also analyzed against a S. aureus strain that is relatively
resistant to AMP killing (methicillin-resistant S. aureus Sanger
252 MRSA), the differences between nicotine-treated and
vehicle-treated skin extracts were less apparent (Figure 1B),
although there was a trend toward a decrease in AMP activity
across all fractions, indicating a global suppression of antimicro-
bial activity. Measurement of the area of inhibition of S aureus
DmprF revealed a significant reduction (ca. 50% reduction) in
overall diffusible antimicrobial activity across multiple fractions
with nicotine (fractions 6-12 and 15-16, Figure 1C). The elution
fraction of cathelicidin-related antimicrobial peptide (CRAMP)
is indicated within fractions 9 and 10. Fractions from nicotine-
treated mice assayed against S. aureus Sanger 252 MRSA
exhibited significantly reduced activity only in fractions 5 and
10 (Figure 1D).
Next, a genetic mouse model was used to evaluate whether
unopposed endogenous nAChR activation can influence epider-
mal antimicrobial activity. For these experiments, we assessed
cutaneous antimicrobial defense in Chga/ mice that lack
chromogranin A and its derived peptide fragment catestatin
(Cst), which acts as an endogenous antagonist of the nAChR
(Mahapatra et al., 2005). Similar to exogenous nicotine appli-
cation, extracts from Chga/mice showed significantly smaller
zones of inhibition than did wild-type mice (Figure 2A), and area
quantification revealed a similar reduction (60% decrease)
of total antimicrobial activity in multiple fractions (fractions 6-7,
9-15).c.
Figure 1. Nicotine Reduces Extractable AMPs from Normal Mouse Skin
(A) Vehicle or nicotine-treated mouse skin extracts incubated with agar containing S. aureus DmprF. HPLC fractions 3-10 are shown (F3-F10). Right side depicts
water and CRAMP peptide as negative and positive controls, respectively. Zone of inhibition refers to the zone of bacterial clearance surrounding the central well.
(B) Vehicle or nicotine-treated mouse skin extracts incubated with agarose containing S. aureus MRSA. Same representation as in (A).
(C) The zone of inhibition (area in mm2) against S. aureusDmprF for fractions 3-16 was quantified. *p < 0.05, #p < 0.01 versus vehicle by two-way ANOVA. Data are
represented as mean ± SEM.
(D) The zone of inhibition (area in mm2) against S. aureus MRSA for fractions 3-16 was quantified. Same representation as in (C).
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mice was indeed due to nAChR activation, we attempted to
rescue Chga/ mice with topical applications of a-bungaro-
toxin, a pharmacologic nAChR antagonist. This treatment
completely restored antimicrobial activity against S. aureus
DmprF in all epidermal fractions from Chga/ mice (Fig-
ure 2B). Similar to nicotine-treated wild-type mouse skin, low
levels of antimicrobial activity were seen when wild-type or
Chga/ mouse skin was assayed against an AMP-resistant
strain of MRSA (Figures 2C and 2D), which is attributed to the
relative AMP resistance of this strain. The remarkable differ-
ences between extracts assayed against the antimicrobial-
susceptible mutant S. aureus DmprF compared with wild-type
S. aureus MRSA indicate that the effects of nAChR activation
are greatly directed toward antimicrobial molecules in the
skin, which may also influence other aspects of inflammation
in response to bacterial infection. Together with the results
seen with topical nicotine application, these results indicate
that increased nAChR activation in skin decreases the potency
of innate antimicrobials to inhibit growth of AMP-susceptible
S. aureus.CellMice Lacking Endogenous nAChR Antagonist
Are More Susceptible to Cutaneous Infection
We next examined the in vivo functional relevance of AMP
suppression using the more relevant skin pathogen MRSA,
because this strain was more resistant to growth inhibition by
skin fractions from nicotine-treated or Chga/ mice. Chga/
mice were challenged by intradermal injection of MRSA and
exhibited larger necrotic skin lesions (81% increase) compared
with wild-type animals (Figures 3A and 3B). Culture of tissue
taken from surrounding skin and kidney showed increase in
bacterial counts both locally and systemically in Chga/ mice
(Figures 3Cand 3D).Wild-type andChga/micewere also chal-
lenged with Group A Streptococcus (GAS) to determine whether
susceptibility to infection in a setting of nAChR activation could
alsopredispose the host to other invasive skin pathogens. Similar
to findings with MRSA, Chga/ mice were more susceptible
to GAS infection than wild-typemice (Figures 4A and 4D) and ex-
hibited larger necrotic skin lesions (67% increase) (Figure 4C)
and greater bacterial burden in skin (Figure 4F). As previously
reported (Aberg et al., 2007), exposure ofwild-typemice to stress
increased infection by GAS, however, stressed Chga/ miceHost & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inc. 279
Figure 2. Unopposed Nicotinic Activation in Chga/ Mice Reduces Extractable AMPs and Is Reversed by Topical nAChR Antagonist
(A) Topically treated vehicle or a-bungarotoxin (100nM) Chga+/+ and Chga/mouse skin extracts skin extracts against S. aureus DmprF. The zone of inhibition
(area in mm2) against S. aureus DmprF for fractions 5-16 from Chga+/+ and Chga/ vehicle-treated skin extracts was quantified. *p < 0.05, #p < 0.01 versus
vehicle by two-way ANOVA. Data are represented as mean ± SEM.
(B) a-Bungarotoxin rescued antimicrobial activity in Chga/mouse skin against S. aureus DmprF. HPLC fraction 11 is shown from vehicle and a-bungarotoxin-
treated Chga+/+ and Chga/ mice. NS, not significant.
(C) Topically treated vehicle or a-bungarotoxin (100 nM) Chga+/+ and Chga/mouse skin extracts against S. aureusMRSA. The zone of inhibition (area in mm2)
against S. aureus MRSA for fractions 5-16 from Chga+/+ and Chga/ vehicle-treated skin extracts was quantified. Same representation as in (A). NS, not
significant.
(D) a-Bungarotoxin effects on Chga/ mouse skin against S. aureus MRSA. HPLC fraction 11 is shown from vehicle and a-bungarotoxin-treated Chga+/+ and
Chga/ mice.
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wild-type mice (50% decrease) (Figures 4B, 4C, and 4E).
Furthermore, when Chga/ mice were compared with each
other, they showed similar susceptibility to infection with or
without stress (Figures 4C, 4D, and 4E). Skin culture and local
bacterial counts showed results similar to lesion size (Figure 4F).
Stress Activates Nicotinic Signaling to Increase
Susceptibility to Infection
To further confirm and extend the physiologic relevance of infec-
tions in the setting of nAChR activation, we next studied the
response to PS. Prior work has shown that levels of Ach increase
during stress (Schlereth et al., 2007), and stressed individuals
appear to be more susceptible to a wide range of opportunistic280 Cell Host & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Ininfections (Ashcraft and Bonneau, 2008; Wu et al., 2005). The
elements responsible for increasing infection after stress are
incompletely understood. To further establish the role of nAChR
activation in stress, wild-type stressed mice were also treated
with a-bungarotoxin. This treatment with a topical Ach receptor
antagonist, selective for the a-7 nAChR, rescued the increase in
susceptibility to GAS infection induced by stress as seen by
a reduction in lesion size (Figures 4G, 4H, and 4I) and bacterial
burden in skin (Figure 4J).
AMP Expression Decreases following Increased
Nicotinic Activation
To identify potential candidate AMPs suppressed by nicotinic
activation, we selectively analyzed the gene expression of thec.
Figure 3. Mice Lacking Endogenous nAChR Antagonist Are More Susceptible to Cutaneous MRSA Infection
(A) Wild-type (Chga+/+) mice were injected intradermally with MRSA. A representative photograph of day 4 lesions is shown.
(B) Chga/ mice were injected intradermally with MRSA and are represented as described in (A).
(C) Lesion size in mm2 was calculated for day 4 lesions. *p < 0.05 by unpaired t test.
(D)Day4 lesionswere excised fromChga+/+andChga/mice for quantitation of bacteria. TheCFU/mlMRSA inday 4 lesions is shown. *p< 0.05byunpaired t test.
(E)Kidneyswereexcised4days following injectionofMRSA.TheCFU/mlMRSAonday4 isshown. *p<0.05byunpaired t test.All dataare representedasmean±SEM.
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sins, inChga/versuswild-typemice. Innormal, uninfectedskin,
a significant reduction (50%) in the mRNA abundance of Camp
was also seen inChga/mice (data not shown). During infection
with GAS, Chga/mice exhibited a further significant reduction
in the expression of the mouse cathelicidin gene Camp (55%
reduction) and mouse b-defensin 4 (mBD4) (70% reduction),
but not KC gene expression, which is the murine homolog of
human IL-8 (Figure 5A). No change in the gene expression of
two additional proinflammatory cytokines, IL-6 and IL-8, was
observed between Chga+/+ or Chga/mice (data not shown). A
slight decrease in mouse b-defensin 14 (mBD14) was also seen,
but the difference did not reach significance (data not shown).
Reductions in AMP gene expression were accompanied by a
concomitant reduction in the abundance of protein as detected
by immunostaining. GAS lesions fromChga/mice showed less
immunofluorescent staining for both CRAMP (Figure 5B) and
mBD3 compared with wild-type lesions (Figure 5C), but this does
not exclude the contribution of other AMPs to this response. No
stainingwasobservedwith IgGcontrol (Figure5D).Further studies
are ongoing to identify alterations in the expression of additional
cutaneous AMPs or cytokines following nAChR activation.
nAChR Activation by Ach Reduces AMP Gene
Expression and Antimicrobial Activity in Epidermal
Keratinocytes
To determine whether AMP suppression was attributable, at
least in part, to direct cholinergic activation of epidermal cells,Cellisolated cultured normal human keratinocytes were stimulated
with Ach in the presence or absence of nAChR antagonists,
and changes in the gene expression of cathelicidin and b-defen-
sin was analyzed. Because constitutive expression of AMPs
is relatively low in cultured keratinocytes due to the lack of
necessary components required for AMP expression seen in
normal skin, in vitro keratinocyte cultures must be stimulated
with varying exogenous molecules to induce the expression
of AMPs. Normal human epidermal keratinocytes (NHEK)
were stimulated to increase expression of human cathelicidin
(CAMP) by exposure to VD3 and MALP-2, a TLR-2 agonist,
whereas MALP-2 alone was used as a positive control for
maximal expression of human beta-defensin 2 (hBD-2, DefB2)
(Schauber et al., 2006). NHEKs stimulated with Ach demon-
strated a statistically significant dose-dependent reduction in
the expression of CAMP and DefB2 at concentrations at 0.01–
0.1 nM compared with the positive controls, with the greatest
statistical significance occurring at 0.01 nM Ach (data not
shown). At .01 nM Ach, the gene expression of CAMP was
reduced to 68-fold over untreated NHEKs compared with 292-
fold with the positive control of VD3 and MALP-2, while the
expression of DefB2 was reduced to 23-fold over untreated
NHEKs compared with 52-fold with the positive control of
MALP-2 (data not shown). Therefore, we next examined whether
this reduction in gene expression could be reversed using Ach
nAChR antagonists. The suppression of both CAMP and
DefB2 by 0.01nM Ach was rescued by the presence of the
endogenous nicotinic antagonist encoded by Chga, catestatinHost & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inc. 281
Figure 4. Stress Activates Nicotinic Signaling to Increase Susceptibility to Infection and Mimics Phenotype of Chga/ Mice
(A) Control Chga+/+ mice were injected intradermally with GAS. A representative photograph of day 4 lesions is shown.
(B) Control Chga/ mice were injected intradermally with GAS and are represented as in (A).
(C) Lesion size in mm2 was calculated in each group for day 1 and day 4 lesions. *p < 0.05 by unpaired t test.
(D) Psychological stressed Chga+/+ mice mimic phenotype of control Chga/ mice. Mice were injected intradermally with GAS and are represented as in (A).
(E) Susceptibility to GAS infection in Chga/mice is not exacerbated by stress. Psychological stressed Chga/mice were injected intradermally with GAS and
are represented as in (A).
(F) Day 4 lesions were excised from control or stressed Chga+/+ and Chga/ mice for quantitation of bacteria. The CFU/ml of GAS in day 4 lesions is shown.
*p < 0.05 by unpaired t test.
(G) Wild-type mice were subjected to PS and simultaneously treated topically with vehicle for 3 days and then injected with GAS. A representative photograph of
day 4 lesions is shown.
(H) Wild-type mice were subjected to PS and simultaneously treated topically with 100 nM a-bungarotoxin for 3 days and then injected with GAS. Lesions are
represented as in (G).
(I) Lesion size in mm2 was calculated for day 4 lesions. *p < 0.05 by unpaired t test.
(J) Day 4 lesions were excised for quantitation of bacteria. The CFU/ml of GAS in day 4 lesions is shown. *p < 0.05 by unpaired t test. All data are represented as
mean ± SEM.
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a-bungarotoxin (Figure 6B). Similar results were observed with
another nAChR antagonist, mecamylamine (data not shown).
The reduction in CAMP gene expression was accompanied by
decreased protein production of hCAP18 protein as detected
by immunofluorescent staining with antibody directed against
the LL-37 domain (see Figure S1 available online). The specificity
of this response to nAChR activation was further confirmed by282 Cell Host & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Ina dose-dependent suppression of CAMP and DefB2 gene
expression in NHEKs observed with nicotine, but not with the
muscarinic receptor agonist muscarine, and the b-adrenergic
receptor agonist, propranolol (data not shown).
To evaluate whether cholinergic activation in NHEKs also
inhibits their ability to restrict the growth of bacteria, lysates
of NHEKs treated with either Ach in the presence or absence
of nAChR antagonists were incubated with S. aureus DmprF.c.
Figure 5. Cathelicidin and Defensin AMPs’ Expression Decreases following Increased Nicotinic Activation
(A)Chga+/+ andChga/mice were injected intradermally with of GAS. Lesions were excised after 24 hr for analysis of AMP gene expression. The relative expres-
sionof cathelicidin (Camp) andhumanbeta-defensins4and14 (DefB4andDefB14) wascalculatedbyqPCRandnormalized toGAPDH. *p<0.05byunpaired t test.
(B) GAS lesions from Chga+/+ (top) and Chga/ (bottom) mice were subjected to immunofluorescent staining for CRAMP. Images shown at 10x magnification
(left) show region magnified at 40x (right), indicated by white box. Scale bar represents 50 mM.
(C) GAS lesions from Chga+/+ (top) and Chga/ (bottom) mice were subjected to immunofluorescent staining for mBD3. Same representation as in (B).
(D) GAS lesions immunostained with rabbit IgG.
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gene expression with VD3 and MALP-2 increased their ability to
inhibit bacterial growth compared to untreated cells (Figure 6C).
However, the presence of Ach significantly suppressed the
capacity of lysates to inhibit bacterial growth, and both Cst
and a-bungarotoxin reversed the suppression of antimicrobial
activity to levels observed with the positive control.Suppression of Cathelicidin by Cholinergic Signaling
Is a Critical Component for the Susceptibility
to Cutaneous Infection
To determine if diminished cathelicidin is responsible in part for
the observed susceptibility to infection seen following nAChR
activation, cathelicidin-deficient mice (Camp/)mice were sub-
jected to PS in the presence or absence of topical a-bungaro-
toxin, and subsequently challenged with GAS. Vehicle-treated
wild-type mice (Figure 7A) exhibited lesions comparable in sizeCellto vehicle-treated Camp/ mice (Figure 7B). a-Bungarotoxin
treated wild-type mice (Figure 7C) compared with a-bungaro-
toxin Camp/ mice (Figure 7D) also exhibited comparable
lesion size. Quantification of the lesion size revealed that
only vehicle-treated wild-type mice demonstrated a significant
increase in lesion size at both 24 and 96 hr (Figure 7E) and
greater bacterial burden in both the skin (Figure 7F) and spleen
(Figure 7G) compared with a-bungarotoxin-treated wild-type
mice. The lack of significant differences between stressed
a-bungarotoxin-treated versus vehicle-treated Camp/ mice
indicates that cathelicidin is a large fraction of AMP activity
that is suppressed during either PS or nAChR activation.DISCUSSION
At the interface with the external world, resident epithelia
and bone-marrow-derived cells employ multilayered immuneHost & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inc. 283
Figure 6. Cholinergic Activation by Ach Reduces AMP Gene Expression and Antimicrobial Activity in Epidermal Keratinocytes
(A) Keratinocytes were stimulated for 24 hr with 1,25 (OH)2 vitamin D3 (VD3) and MALP-2 in the presence or absence of Ach (Ach), catestatin (Cst), or a-bungar-
otoxin (Bung). Relative mRNA expression of cathelicidin (Camp) (left) and human beta-defensin 2 (DefB2) (right) by qPCR and normalized to GAPDH. *p < 0.05
versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and Bung.
(B) Keratinocytes were stimulated as above and cell lysates incubated with S. aureus DmprF. Surviving bacteria after 12 hr is shown. *p < 0.05 versus
VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and a-bungarotoxin antagonists. All data are represented as mean ± SEM.
(C) Keratinocytes were stimulated as above, and cell lysates were incubated with S. aureus DmprF. Surviving bacteria after 12 hr is shown. *p < 0.05 versus
VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and a-Bugarotoxin antagonists. All data are represented by mean ± SEM.
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establish that nAChR activation suppresses innate antimicrobial
defense of the skin. The decrease in early host responses
to pathogen invasion results in enhanced infection in mouse
models of invasiveMRSA and GAS infection. Furthermore, these
findings are consistent with clinical observations in humans that
have increased incidence of infection as a consequence of nico-
tine exposure or prolonged stress, two common events that
enhance nAChR activation. These observations provide insight
into an element previously unknown to influence the suscepti-
bility to infection, and present immediate opportunities to
improve disease resistance in significant human populations
exposed to stress.
The direct effects of nAChR stimulation were assessed by
using topical nicotine specific to nAChRs. The diminished
capacity of nicotine-treated extracts to impart AMP activity
against the AMP-susceptible mutant, S. aureus DmprF, com-
pared with MRSA, indicates that the nAChR activation promotes284 Cell Host & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Ina selective reduction of antimicrobial peptide activity, as
opposed to other antimicrobial molecules in the skin. The direct
effect of nAChR activation on AMP activity was further confirmed
by using Chga/ mice having unopposed nAChR activation,
because these extracts also exhibited a greater diminished
capacity against S. aureus DmprF compared with MRSA when
evaluated against wild-type mice. The physiologic relevance of
this was confirmed using two models of infection with MRSA
and GAS, which represent two important pathogens that
account for most acute skin infections. However, there is
a dramatic difference between themodest changes in antimicro-
bial activity against MRSA in our radial diffusion assays, com-
pared with S. aureus DmprF, and the very substantial and
impressive change in lesion size. This indicates that the dimin-
ished immune response following nAChR activation is quite
complex and likely involves the suppression of immunostimula-
tory functions normally induced by the increase in or activation of
AMPs following infection. The increase in the number of survivingc.
Figure 7. Suppression of Cathelicidin by Cholinergic Signaling Is a Critical Component for the Susceptibility to Cutaneous Infection
(A) Stress increases susceptibility to GAS infection in wild-type mice. Wild-type mice were subjected to PS and simultaneously treated topically with vehicle for
3 days and then injected with GAS. A representative photograph of day 4 lesions is shown.
(B) Stress does not increase susceptibility to GAS infection in Cramp/ mice. Mice were subjected to PS and simultaneously treated topically with vehicle for
3 days and then injected with GAS. Lesions are represented as in (A).
(C) Wild-type mice are rescued from susceptibility GAS infection by a-bungarotoxin treatment during stress. Mice were subjected to PS and simultaneously
treated topically with a-bungarotoxin (a-Bung) for 3 days and then injected with GAS. Lesions are represented as in (A).
(D) Cramp/mice are not rescued from susceptibility GAS infection by a-bungarotoxin treatment during stress. Mice were subjected to PS and simultaneously
treated topically with a-bungarotoxin (a-Bung) for 3 days and then injected with GAS. Lesions are represented as in (A).
(E) Lesion size (in mm2) was calculated in each group for day 1 and day 4 lesions. *p < 0.05 by unpaired t test.
(F) Day 4 lesions were excised from stressedCramp+/+ andCram/ vehicle or a-bungarotoxin-treatedmice for quantitation of bacteria. The CFU/ml GAS in day 4
lesions is shown. *p < 0.05 by unpaired t test.
(G) Spleens were excised from stressed Cramp+/+ and Cramp/ vehicle or a-bungarotoxin-treated mice 4 days following injection for quantitation of bacteria.
The CFU/ml GAS in spleen is shown. *p < 0.05 by unpaired t test. All data are represented as mean ± SEM.
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phagocytes and/or oxidative killing capacity, which may be
a direct or indirect consequence of global AMP suppression
during stress.
These results substantiate the detrimental effects that
increased nAChR activation caused by stress and/or smoking
have on the host response to infection. Interestingly, most
epithelia, including the gut and lung similarly respond to
nAChR activation through immunosuppression of immune cells
(Giebelen et al., 2009; Pullan et al., 1994). This dampened
response to infection may increase dissemination of bacteria
from initial sites of infection to distal organs or tissues. Catechol-
amines have been shown to increase the expression of virulence
factors to promote survival of pathogens (Freestone et al., 2008).
Thus, the effect of the stress response may be twofold to
suppress host response to infection, while enhancing the micro-
environment for survival and proliferation of bacteria. It is attrac-
tive to speculate that some microorganisms might utilize this
system to enhance their pathogenic potential, a concept that
should be investigated in the future.CellThe focus of this investigation was on the epithelial defense
against bacterial infection, in particular keratinocytes of the
epidermis. Normal, uninfected skin was used for topical nicotine
and antagonist treatment, and skin extracts were evaluated from
Chga/ mice to allow for the extraction of acid-soluble AMPs
and selective exclusion of infiltrating immune cells and reactive
oxygen species. This approach enabled analysis of direct effects
of nAChR stimulation or antagonism, and is justified because
keratinocytes comprise 95% of the cells within the epidermis
and have previously been shown to be an essential cell type
for production of AMPs in the skin (Braff et al., 2005a, 2005b).
Nonetheless, the topical administration of nicotine may expose
not only epidermal keratinocytes, but also other resident epi-
dermal cells including dendritic cells and mast cells that partici-
pate in the response to infection. The results from quantitative
polymerase chain reaction (qPCR) and immunostaining of
bacterial lesions further confirmed that the reduction of selected
AMP expression was primarily observed in the epidermis. The
proportion of nAChR signaling from other cell types relative to
the keratinocyte remains unknown in response to infection andHost & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inc. 285
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anti-inflammatory pathway has been previously shown to be
mediated by vagal nerve stimulation and a7 cholinergic recep-
tors and can decrease inflammatory responses (Tracey, 2007).
Therefore, it is likely that nAChR activation can enhance suscep-
tibility to infection by action on several cell types.
Topical application of a-bungarotoxin rescued Chga/ mice
from suppression of AMP activity, and wild-type mice from
susceptibility to GAS infection. The efficiency with which a-bun-
garotoxin restored AMP levels in skin and the response to infec-
tion to that of controls corroborate our results and establish that
the effects of stress on AMP suppression and susceptibility to
infection are, at least in part, through nAChR signaling. This
becomes relevant in a setting of sustained PS, which appears
to increase susceptibility to invasive infection.
Because a-bungarotoxin is a a7 nAChR antagonist, this
further implicates the a7 subtype in cutaneous immunosuppres-
sion, which now includes epithelial AMPs. nAChR subunit
composition determines both activation and desensitization in
response to specific agonists. Work is currently ongoing to
determine which specific receptor subtypes and signaling path-
ways are responsible for suppression of AMPs. Interestingly,
GCs and/or steroids have been shown to influence acetylcho-
line (Ach) content in tissue (Reinheimer et al., 1998), and modu-
late nAChR activity and sensitization (Valera et al., 1992). This
may account for the partial rescue of AMP suppression in
stressed mice by RU-486, a GC/progesterone receptor antago-
nist (Aberg et al., 2007). This convergent mechanism for the
suppression of AMPs during stress is depicted in Figure S2.
Stress increases both GC and Ach that activates their respec-
tive receptors mAChR, nAChR, and GC receptor. GCs can
further enhance nAChR activation to augment the suppression
of AMP and lipid production. Blocking nAChR and GC receptor
activation using specific antagonists may counteract these
effects to restore normal production of AMPs and lipids to the
epithelial surface.
The in vitro stimulation of keratinocytes with Ach and nAChR
antagonists confirms our in vivo results and indicates a direct
effect of nAChR activation on AMP expression and activity.
Previously published results from other laboratories showed
that nicotine was much more efficient than Ach in inhibiting the
production of proinflammatory cytokines in macrophages, and
virtually no effect was seen with muscarine (Wang et al., 2003).
Our in vitro stimulation with the nAChR agonists Ach and nico-
tine, the adrenergic agonist propranolol, and the muscarinic
agonist muscarine parallels these previous results, as only nico-
tine and Ach were able to suppress gene and protein expression
of AMPs. Furthermore, the nAChRs Cst, a-bungarotoxin, and
mecamylamine were able to reverse the suppression of AMP
gene expression and activity by Ach, with bungarotoxin being
the most effective. Mecamylamine, an a3b4 nAChR antagonist,
was slightly less effective than a-bungarotoxin, an a7 Ach
receptor antagonist, in restoring AMP gene expression, impli-
cating the a7 nAChR as a key subtype involved in AMP suppres-
sion. Although the specificity of Cst for nAChRs in the skin is not
currently known, it appears that it may have a different nAChR
subtype specificity compared with a-bungarotoxin, because
its ability to restore AMP expression of both cathelicidin and
b-defensin 2 was somewhat less effective. However, the ability286 Cell Host & Microbe 7, 277–289, April 22, 2010 ª2010 Elsevier Inof Cst to restore both AMP expression and activity to levels
seen with the control suggests a direct role of Cst in maintaining
AMP expression under normal homeostasis. We previously
determined that Cst expression increases following barrier
disruption and infection (Radek et al., 2008), and Ach levels
increase in skin following UV exposure and tactile stimulation
(Schlereth et al., 2007), which simulates injury. Thus, Cst may
function as an endogenous nAChR antagonist in the skin to
balance the effects of Ach under normal or acute stressed con-
ditions. Under prolonged periods of stress, the ability of Cst to
act as a nAChR antagonist may be limited by the ability of kera-
tinocytes to synthesize or secrete Cst. This would skew the
balance toward increased nAChR activation, suppression of
AMPs, and ultimately increased infection.
The observation that stress did not exacerbate the suscepti-
bility to infection in either Chga/ or Camp/ mice provides
two key pieces of information that are critical toward elucidating
the mechanism behind AMP suppression during stress. First,
GCs, catecholamines, and Ach are all secreted from various
tissues during the stress response. If the effects of either GCs
or catecholamines were the primary cause for susceptibility to
infection during stress, an increase in susceptibility to infection
characterized by larger lesions and a greater bacterial burden
would be expected. This supports the notion that perhaps GCs
and catecholamines may be modifying the nAChR to enhance
the effect of Ach during stress. In parallel, the finding that stress
did not augment the susceptibility to infection in Camp/ mice
implicates cathelicidin as a key AMP involved following cholin-
ergic activation of nAChRs. If other AMPs, such as b-defensins,
were contributing more to the response to stress, larger lesions
and greater bacterial burdenwould be expected as described for
stressed Chga/ mice. This does not exclude the involvement
of other AMPs to the susceptibility to infection during stress,
but it does suggest that the global effects of nAChR signaling
on AMP suppression include cathelicidin. The contribution of
cathelicidin to innate immune function of the skin during infection
is complex and integrates both its antimicrobial and immuno-
modulatory functions that may influence the activity of numerous
peptides produced by the epidermis, including b-defensins,
Psoriasin, or RNase 7, as well as the antimicrobial and proinflam-
matory capacity of infiltrating immune cells. This may explain the
discrepancy between our in vitro and in vivo results. The global
suppression of antimicrobial activity seen with the radial diffu-
sion assays may exacerbate the immunosuppression by nAChR
activation by blocking necessary stimulation of later immune
responses that are AMP-dependent. Because cathelicidin is
also immunomodulatory, this does not rule out the fact that other
immune responses are indirectly dampened by nAChR activa-
tion. Cathelicidin may be a key regulatory peptide for normal
AMP function that directs bothmicrobicidal and immunostimula-
tory functions of additional AMPs in the skin, and its activity
and/or expression may be a direct target of nAChR activation.
Furthermore, cathelicidin is also involved in epidermal perme-
ability homeostasis, because Cramp/ mice exhibit defects in
membrane permeability and lipid content, demonstrating the
interdependence between AMPs and barrier function (Aberg
et al., 2008). This emphasizes the importance of AMP regulation
in host defense, as well as a natural structural component of the
epithelial barrier. Thus, enhanced cholinergic signalingmay likelyc.
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to the increase in bacterial susceptibility.
Collectively, our study identifies two unique pathways of the
epithelial response to infection. First, the AMP response is regu-
lated at the molecular level by Ach via nAChRs and is dependent
upon the presence of the nAChR antagonist, Cst. Second, the
suppression of AMP response to infection during stress is medi-
ated primarily by cathelicidin following increased nAChR stimu-
lation. Further insight into how bacteria utilize the host nAChR
pathway to augment their invasive capacity and virulence will
be critical to our understanding of the pathogen-host interac-
tions at the epithelial interface.
EXPERIMENTAL PROCEDURES
Animals
CHGA wild-type (Chga+/+) and knockout mice (Chga/) were generated as
described previously (Mahapatra et al., 2005) and bred internally. Cramp/
mice were bred internally. C57Bl/6 mice (8–10-week-old males) were
purchased from Jackson Laboratories. All mice were housed in the VA San
Diego VMU. All animal experiments were approved by the VA San Diego
IACUC.
HPLC Purification of Skin Extracts
Mice were sacrificed and dorsal skin extracted overnight in 1 N acetic acid at
4C. Samples were homogenized, and supernatant was lyophilized and dis-
solved in water. HPLC peptide separation was performed on a C18 column
(12 mm, ST 4.6/250). Equilibration was done in 0.1% trifluoroacetic acid.
Peptides were eluted with an acetonitrile gradient (10%–100%). Fractions
were lyophilized and dissolved in 10 ml water.
Radial Diffusion Assay
HPLC fractions were evaluated using the radial diffusion assay as described
elsewhere (Lehrer et al., 1991). Antimicrobial activity was analyzed against
S. aureus DmprF (Peschel et al., 2001) and S. aureus Sanger 252 (MRSA).
Approximately 53 106 cells/ml of bacteria were used. Water was the negative
control. Synthetic CRAMP (32 mM) was the positive control. The zone of inhi-
bition (Area) was quantified using Image J Software.
Topical Nicotine Application
Three-day-old C57Bl/6 neonatal mice had either vehicle (1:1000 ethanol:-
water) or 1 nM nicotine (Sigma) topically applied to skin twice daily for
3 days. Whole mouse skin was excised and subsequently purified by HPLC
for radial diffusion assays (n = 4 per group, repeated twice).
Topical a-Bungarotoxin Application
Vehicle (water) or 100 nM a-bungarotoxin (Sigma) was topically applied to
mouse skin twice daily for 3 days. For some experiments, whole mouse skin
was excised and subsequently purified by HPLC for radial diffusion assays
as described above. For some experiments, mice were also subjected to PS
and injected with bacteria as indicated below (n = 6 per group, repeated twice).
Psychological Stress Model
Micewere subjected to psychological insomnia stress as previously described
(Aberg et al., 2007). Some mice also had topical a-bungarotoxin applied daily
as indicated above during stress. Mice were subsequently injected with
bacteria as described below.
GAS and Staphylococcus aureus Infection
GAS was grown in Todd Hewitt broth (THB) and Staphylococcus aureus was
grown in tryptic soy broth (TSB). Infection was performed as previously
described (Nizet et al., 2001). For GAS, hair was plucked and skin injected
with 100 ml of a mid-logarithmic growth phase of bacteria and sterile Cytodex
beads. On day 4 postinjection, lesions were excised and homogenized in
sterile PBS with 1 mm zirconia beads in a mini bead-beater (BioSpec Prod-Cellucts). Supernatants were diluted and plated on THA or TSA to quantify the
colony-forming units per milliliter (CFU/ml).
Immunohistochemistry on Mouse Skin
Immunohistochemistry was performed on 24 hr GAS lesions and immuno-
stained for CRAMP or mBD3 as previously described (Dorschner et al.,
2001) (Aberg et al., 2007). Cells were counterstained with DAPI. Fluorescent
images were captured on an Olympus BX51 microscope equipped with
a DC71 camera using 10x or 40x objectives (n = 6 per group, repeated twice).
Cell Culture and Stimulation
Normal human keratinocytes were cultured in EpiLife medium (Cascade Bio-
logics) supplemented with 0.06 mM calcium, EDGS, and penicillin/strepto-
mycin. For antimicrobial lysate assays, cells were grown in the same media
without antibiotics for 2 passages prior to stimulation. For RNA and antimicro-
bial assays, cells were grown to confluency and differentiated in high calcium
(1.2 mM) for 3 days prior to stimulation to allow for more uniform expression of
nAChRs. Cells were stimulated for 24 hr separately or in combination with the
following reagents: 1nM 1,25 (OH)2 Vitamin D3 (Sigma), 100 ng/ml MALP-2
(Alexis), 0.01 nM Ach (Sigma), 0.001 nM to 1 mM nicotine (Sigma), 10n M Cst
(Imgenex), 100 nM a-bungarotoxin (Sigma), 5 mM mecamylamine (Sigma).
Keratinocyte Lysate Antimicrobial Assay
Protein was extracted with 1 N acetic acid. Samples were sonicated, lyophi-
lized and dissolved in 100 ml sterile water. Protein concentration was normal-
ized between samples. S. aureus DmprF was grown in TSB overnight and then
subcultured in 30% TSB, 25 mm NaHCO3, and 1 mm NaHPO4 until log phase
was reached. 103 bacteria was incubated with lysates from stimulated kerati-
nocytes (7 mg total protein) at 37C in 30% TSB, 25 mm NaHCO3, 1 mm
NaHPO4. Bacterial growth over time was determined by optical density at
600 nm. The number of surviving bacteria was determined after 4, 8, and 12 hr.
qPCR for Skin and Keratinocytes
RNA from mouse skin and keratinocytes was extracted as described else-
where (Schauber et al., 2006). Assays were performed in triplicate and
repeated at least three times. All assays using mouse skin RNA used at least
five mice per group and were repeated twice.
Statistical Analysis
Data were analyzed using GraphPad Prism, v4 (GraphPad Software).
The means and standard error of the mean (SEM) were calculated for each
data set. Data were analyzed by an unpaired t test or analysis of variance
(ANOVA) with post-tests when appropriate, and p values < 0.05 were consid-
ered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and can be found with this
article online at doi:10.1016/j.chom.2010.03.009.
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